Martin Kömhoff Selected Research

kifunensine

12/2021

Golgi Alpha1,2-Mannosidase IA Promotes Efficient Endoplasmic Reticulum-Associated Degradation of NKCC2.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Martin Kömhoff Research Topics

Disease

7	Bartter Syndrome (Syndrome, Bartter) 12/2021 - 07/2002
3	Neoplasms (Cancer) 01/2008 - 08/2007
3	Carcinogenesis 01/2008 - 01/2006
2	Gitelman Syndrome 01/2022 - 01/2017
2	Melanoma (Melanoma, Malignant) 01/2017 - 05/2016
2	Polyuria 05/2016 - 11/2005
2	Hypertension (High Blood Pressure) 07/2007 - 01/2004
2	Acute Kidney Injury (Acute Renal Failure) 11/2005 - 01/2004
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2022
1	Alkalosis 01/2022
1	Mania (Manias) 12/2021
1	Kidney Diseases (Kidney Disease) 01/2021
1	Polyhydramnios 04/2019
1	Hematuria 01/2017
1	Methylmalonic acidemia 01/2017
1	Proteinuria 01/2017
1	Homocystinuria 01/2017
1	Vitamin B 12 Deficiency (Vitamin B12 Deficiency) 01/2017
1	Hemolysis 01/2017
1	End Stage Liver Disease 03/2015
1	Breast Neoplasms (Breast Cancer) 01/2015
1	IGA Glomerulonephritis (IGA Nephropathy) 01/2015
1	Pulmonary Hypertension 08/2013
1	Thrombotic Microangiopathies 08/2013
1	Atypical Hemolytic Uremic Syndrome 08/2012
1	Vascular Tissue Neoplasms 01/2008
1	Hyperplasia 08/2007
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 08/2007
1	Myocardial Infarction 07/2007
1	Hypokalemia 04/2005
1	Inflammation (Inflammations) 01/2004
1	Diabetic Nephropathies (Diabetic Nephropathy) 01/2004
1	Edema (Dropsy) 01/2004
1	Heart Failure 01/2004

Drug/Important Bio-Agent (IBA)

7	SaltsIBA 01/2022 - 07/2002
3	Proteins (Proteins, Gene)FDA Link 12/2021 - 08/2012
3	PPAR-betaIBA 01/2008 - 01/2006
3	ProstaglandinsIBA 08/2007 - 01/2004
3	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 07/2007 - 07/2002
2	ThiazidesIBA 01/2022 - 01/2017
2	AntigensIBA 01/2017 - 05/2016
2	Vitamin B 12 (Cyanocobalamin)FDA LinkGeneric 01/2017 - 08/2013
2	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 08/2007 - 01/2006
2	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 07/2007 - 01/2004
1	Mitochondrial DNA (mtDNA)IBA 01/2022
1	Member 3 Solute Carrier Family 12IBA 01/2022
1	kifunensineIBA 12/2021
1	Cycloheximide (Cicloheximide)IBA 12/2021
1	Mannose (D-Mannose)IBA 12/2021
1	Proteasome InhibitorsIBA 12/2021
1	Member 1 Solute Carrier Family 12IBA 12/2021
1	benzyloxycarbonylleucyl-leucyl-leucine aldehydeIBA 12/2021
1	SymportersIBA 01/2021
1	Furosemide (Lasix)FDA LinkGeneric 01/2017
1	Sodium Chloride SymportersIBA 01/2017
1	HomocysteineIBA 01/2017
1	AmmoniaIBA 03/2015
1	prostacyclin synthetase (prostacyclin synthase)IBA 01/2015
1	Complement Factor B (Factor B)IBA 08/2012
1	Complement Factor H (Factor H)IBA 08/2012
1	ThrombomodulinIBA 08/2012
1	chemotactic factor inactivatorIBA 08/2012
1	Fibrinogen (Factor I)FDA Link 08/2012
1	Complement System Proteins (Complement)IBA 08/2012
1	Membrane Cofactor ProteinIBA 08/2012
1	AutoantibodiesIBA 08/2012
1	Salicylic Acid (2 Hydroxybenzoic Acid)FDA LinkGeneric 08/2011
1	Messenger RNA (mRNA)IBA 08/2007
1	Dinoprostone (PGE2)FDA Link 08/2007
1	Celecoxib (Celebrex)FDA Link 07/2007
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 07/2007
1	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 01/2006
1	Prostaglandins EIBA 11/2005
1	Indomethacin (Indometacin)FDA LinkGeneric 11/2005
1	ReninIBA 02/2004
1	SodiumIBA 01/2004

Therapy/Procedure

1	Precision Medicine 04/2019
1	Kidney Transplantation 01/2004